Full View

Comparative efficacy and safety of radiotherapy/cetuximab versus radiotherapy/chemotherapy for locally advanced head and neck squamous cell carcinoma patients …

M Mei, YH Chen, T Meng, LH Qu… - … in medical oncology, 2020 - journals.sagepub.com
Background: Cetuximab (CTX) has been approved to be administered concurrently with
radiotherapy (RT) to treat locally advanced head and neck squamous cell carcinoma …
被引用次数：13 相关文章
[PDF] bjmu.edu.cn

[PDF][PDF] Mei Mei, Yu-Huan Chen, Tian Meng, Ling-Han Qu, Zhi-Yong Zhang and Xiao Zhang

X Zhang, M Mei, YH Chen, T Meng, LH Qu - 2020 - ss.bjmu.edu.cn
Background: Cetuximab (CTX) has been approved to be administered concurrently with
radiotherapy (RT) to treat locally advanced head and neck squamous cell carcinoma …
[HTML] nih.gov

[HTML][HTML] Comparative efficacy and safety of radiotherapy/cetuximab versus radiotherapy/chemotherapy for locally advanced head and neck squamous cell carcinoma …

M Mei, YH Chen, T Meng, LH Qu… - … Advances in Medical …, 2020 - ncbi.nlm.nih.gov
Background: Cetuximab (CTX) has been approved to be administered concurrently with
radiotherapy (RT) to treat locally advanced head and neck squamous cell carcinoma …

Comparative efficacy and safety of radiotherapy/cetuximab versus radiotherapy/chemotherapy for locally advanced head and neck squamous cell carcinoma patients …

M Mei, YH Chen, T Meng, LH Qu… - Therapeutic …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Cetuximab (CTX) has been approved to be administered concurrently with
radiotherapy (RT) to treat locally advanced head and neck squamous cell carcinoma …

Comparative efficacy and safety of radiotherapy/cetuximab versus radiotherapy/chemotherapy for locally advanced head and neck squamous cell carcinoma patients …

M Mei, YH Chen, T Meng, LH Qu… - Therapeutic …, 2020 - search.ebscohost.com
Background: Cetuximab (CTX) has been approved to be administered concurrently with
radiotherapy (RT) to treat locally advanced head and neck squamous cell carcinoma …

Comparative efficacy and safety of radiotherapy/cetuximab versus radiotherapy/chemotherapy for locally advanced head and neck squamous cell carcinoma patients …

M Mei, YH Chen, T Meng, LH Qu… - … Advances in Medical …, 2020 - europepmc.org
Background Cetuximab (CTX) has been approved to be administered concurrently with
radiotherapy (RT) to treat locally advanced head and neck squamous cell carcinoma …

[引用][C] Mei Mei, Yu-Huan Chen, Tian Meng, Ling-Han Qu, Zhi-Yong Zhang and Xiao Zhang

X Zhang, M Mei, YH Chen, T Meng, LH Qu - 2020